These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 33010624)
1. Synthesis, ADMET prediction and reverse screening study of 3,4,5-trimethoxy phenyl ring pendant sulfur-containing cyanopyrimidine derivatives as promising apoptosis inducing anticancer agents. Nainwal LM; Shaququzzaman M; Akhter M; Husain A; Parvez S; Khan F; Naematullah M; Alam MM Bioorg Chem; 2020 Nov; 104():104282. PubMed ID: 33010624 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930 [TBL] [Abstract][Full Text] [Related]
3. Methylene-bearing sulfur-containing cyanopyrimidine derivatives for treatment of cancer: Part-II. Akhtar W; Nainwal LM; Kaushik SK; Akhtar M; Shaquiquzzaman M; Almalki F; Saifullah K; Marella A; Alam MM Arch Pharm (Weinheim); 2020 May; 353(5):e1900333. PubMed ID: 32115728 [TBL] [Abstract][Full Text] [Related]
4. Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights. Sheta YS; Sarg MT; Abdulrahman FG; Nossier ES; Husseiny EM Bioorg Chem; 2024 Aug; 149():107471. PubMed ID: 38823311 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of N-(4-substituted)-3-phenylisoxazolo[5,4-d]pyrimidin-4-amine derivatives as apoptosis-inducing cytotoxic agents. Gaikwad NB; Bansod S; Mara A; Garise R; Srinivas N; Godugu C; Yaddanapudi VM Bioorg Med Chem Lett; 2021 Oct; 49():128294. PubMed ID: 34333139 [TBL] [Abstract][Full Text] [Related]
6. Novel pyrazolo[3,4-d]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation. Gaonkar S; Savanur MA; Nadaf AA; Najare MS; Mantur S; Garbhagudi M; Mulla SI; Khazi IAM Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900296. PubMed ID: 32073686 [TBL] [Abstract][Full Text] [Related]
7. Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling. Ahmad Sheikh K; Parveen D; Mumtaz Alam M; Azam F; Ahmed Khan M; Akhter M; Tasneem S; Meenu ; Parvez S; Imtiyaz K; Rizvi MA; Shaquiquzzaman M Bioorg Chem; 2024 Jun; 147():107336. PubMed ID: 38636431 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety. Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents. Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366 [TBL] [Abstract][Full Text] [Related]
10. Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches. Farag AK; Hassan AHE; Chung KS; Lee JH; Gil HS; Lee KT; Roh EJ Bioorg Chem; 2020 Oct; 103():104121. PubMed ID: 32745753 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma. Ahmed NM; Youns M; Soltan MK; Said AM J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890 [TBL] [Abstract][Full Text] [Related]
12. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies. Murahari M; Prakash KV; Peters GJ; Mayur YC Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs. Attia MH; Elrazaz EZ; El-Emam SZ; Taher AT; Abdel-Aziz HA; Abouzid KAM Bioorg Chem; 2020 Jan; 94():103458. PubMed ID: 31785854 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346 [TBL] [Abstract][Full Text] [Related]
15. New fused pyrimidine derivatives with anticancer activity: Synthesis, topoisomerase II inhibition, apoptotic inducing activity and molecular modeling study. Nemr MTM; AboulMagd AM Bioorg Chem; 2020 Oct; 103():104134. PubMed ID: 32750610 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors. Wang R; Yu S; Zhao X; Chen Y; Yang B; Wu T; Hao C; Zhao D; Cheng M Eur J Med Chem; 2020 Feb; 188():112024. PubMed ID: 31923858 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety. Zhao PL; Li YH; Yang HK; Chen P; Zhang B; Sun Q; Li Q; You WW Eur J Med Chem; 2016 Aug; 118():161-9. PubMed ID: 27128180 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel 7 Liu YM; Chen CH; Yeh TK; Liou JP Future Med Chem; 2019 May; 11(9):959-974. PubMed ID: 30789758 [No Abstract] [Full Text] [Related]
20. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]